Market Cap | 1.74M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -6.85M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 6.00% |
Sales | 7.47M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -17.00% |
Dividend | N/A | Price/Book | 0.19 | EPS next 5Y | - | 52W High Chg | -66.00% |
Recommedations | - | Quick Ratio | 1.00 | Shares Outstanding | 569.09M | 52W Low Chg | 88.00% |
Insider Own | - | ROA | -14.37% | Shares Float | - | Beta | 0.57 |
Inst Own | - | ROE | -417.24% | Shares Shorted/Prior | -/- | Price | 0.00300 |
Gross Margin | 13.06% | Profit Margin | -91.71% | Avg. Volume | 637,086 | Target Price | - |
Oper. Margin | -112.05% | Earnings Date | - | Volume | 66,001 | Change | 11.11% |
Stevia Corp., a farm management and healthcare company, focuses on developing plant breeding and agricultural methodologies. The company invests in the research and development, and IP acquisition, as well as manages propagation, nursery, and plantations. It also provides services to contract growers and other industry growers. The company was formerly known as Interpro Management Corp. and changed its name to Stevia Corp. in March 2011. Stevia Corp. was incorporated in 2007 and is based in Indianapolis, Indiana.